Thursday 21 February, 2008

Patent Challenges: A favorable indication for Generics

Chron. com have published a good article entitled "Market Spotlight: Generic Drugs" Emboldened by favorable court rulings and the need to gain an early foothold in the market, generic drug developers are increasingly challenging lucrative drug patents.
In many cases those challenges have been coming in the form of at-risk launches, where a generic version of a patented drug is sold before the patent expires. Please read complete article on following link

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker